News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
377,873 Results
Type
Article (24848)
Company Profile (35)
Press Release (352990)
Multimedia
Podcasts (90)
Webinars (10)
Section
Business (122556)
Career Advice (1458)
Deals (17847)
Drug Delivery (65)
Drug Development (43830)
Employer Resources (100)
FDA (8956)
Job Trends (8766)
News (195753)
Policy (17730)
Tag
Academia (1499)
Academic (1)
Accelerated approval (5)
Adcomms (13)
Allergies (59)
Alliances (33916)
ALS (69)
Alzheimer's disease (874)
Antibody-drug conjugate (ADC) (108)
Approvals (8997)
Artificial intelligence (204)
Autoimmune disease (18)
Automation (15)
Bankruptcy (163)
Best Places to Work (7253)
BIOSECURE Act (12)
Biosimilars (62)
Biotechnology (26)
Bladder cancer (72)
Brain cancer (21)
Breast cancer (245)
Cancer (1943)
Cardiovascular disease (143)
Career advice (1240)
Career pathing (24)
CAR-T (99)
CDC (25)
Cell therapy (324)
Cervical cancer (17)
Clinical research (36112)
Collaboration (774)
Company closure (1)
Compensation (158)
Complete response letters (12)
COVID-19 (1548)
CRISPR (42)
C-suite (181)
Cystic fibrosis (64)
Data (2027)
Decentralized trials (2)
Denatured (28)
Depression (32)
Diabetes (242)
Diagnostics (3493)
Digital health (12)
Diversity (4)
Diversity, equity & inclusion (31)
Drug discovery (87)
Drug pricing (81)
Drug shortages (21)
Duchenne muscular dystrophy (85)
Earnings (56427)
Editorial (34)
Employer branding (14)
Employer resources (88)
Events (56297)
Executive appointments (491)
FDA (10007)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (1)
Frontotemporal dementia (6)
Funding (530)
Gene editing (83)
Generative AI (21)
Gene therapy (267)
GLP-1 (495)
Government (2466)
Grass and pollen (4)
Guidances (153)
Healthcare (10450)
Huntington's disease (17)
IgA nephropathy (27)
Immunology and inflammation (95)
Immuno-oncology (9)
Indications (26)
Infectious disease (1642)
Inflammatory bowel disease (101)
Inflation Reduction Act (10)
Influenza (31)
Intellectual property (79)
Interviews (270)
IPO (8519)
IRA (35)
Job creations (1864)
Job search strategy (1026)
Kidney cancer (9)
Labor market (30)
Layoffs (263)
Leadership (19)
Legal (4561)
Liver cancer (41)
Lung cancer (300)
Lymphoma (141)
Machine learning (5)
Management (34)
Manufacturing (247)
MASH (64)
Medical device (6749)
Medtech (6753)
Mergers & acquisitions (9795)
Metabolic disorders (559)
Multiple sclerosis (68)
NASH (9)
Neurodegenerative disease (65)
Neuropsychiatric disorders (17)
Neuroscience (1277)
NextGen: Class of 2025 (3558)
Non-profit (2744)
Now hiring (6)
Obesity (261)
Opinion (177)
Ovarian cancer (56)
Pain (63)
Pancreatic cancer (68)
Parkinson's disease (103)
Partnered (12)
Patents (183)
Patient recruitment (84)
Peanut (26)
People (29298)
Pharmaceutical (10)
Pharmacy benefit managers (11)
Phase I (10799)
Phase II (15412)
Phase III (12960)
Pipeline (1307)
Policy (141)
Postmarket research (1694)
Preclinical (4697)
Press Release (31)
Prostate cancer (119)
Psychedelics (20)
Radiopharmaceuticals (160)
Rare diseases (289)
Real estate (2700)
Recruiting (38)
Regulatory (12205)
Reports (25)
Research institute (1365)
Resumes & cover letters (222)
Rett syndrome (6)
RNA editing (5)
RSV (34)
Schizophrenia (54)
Series A (95)
Series B (53)
Service/supplier (3)
Sickle cell disease (41)
Special edition (12)
Spinal muscular atrophy (71)
Sponsored (19)
Startups (1613)
State (1)
Stomach cancer (14)
Supply chain (40)
Tariffs (39)
The Weekly (60)
Vaccines (525)
Venture capital (29)
Weight loss (152)
Women's health (25)
Worklife (14)
Date
Today (3)
Last 7 days (237)
Last 30 days (1163)
Last 365 days (19429)
2025 (10576)
2024 (20727)
2023 (22822)
2022 (29379)
2021 (31154)
2020 (30344)
2019 (26026)
2018 (19254)
2017 (18130)
2016 (17560)
2015 (19990)
2014 (16644)
2013 (14560)
2012 (14454)
2011 (13922)
2010 (13116)
Location
Africa (565)
Alabama (46)
Alaska (6)
Arizona (94)
Arkansas (7)
Asia (21928)
Australia (3690)
California (4281)
Canada (1417)
China (421)
Colorado (214)
Connecticut (221)
Delaware (119)
Europe (52126)
Florida (757)
Georgia (160)
Idaho (22)
Illinois (352)
India (19)
Indiana (241)
Iowa (6)
Japan (163)
Kansas (60)
Kentucky (12)
Louisiana (6)
Maine (27)
Maryland (593)
Massachusetts (3295)
Michigan (139)
Minnesota (204)
Mississippi (1)
Missouri (37)
Montana (9)
Nebraska (9)
Nevada (49)
New Hampshire (31)
New Jersey (1440)
New Mexico (12)
New York (1311)
North Carolina (679)
North Dakota (5)
Northern California (1892)
Ohio (121)
Oklahoma (12)
Oregon (20)
Pennsylvania (990)
Puerto Rico (18)
Rhode Island (25)
South America (847)
South Carolina (21)
Southern California (1634)
Tennessee (83)
Texas (646)
United States (16517)
Utah (137)
Virginia (103)
Washington D.C. (54)
Washington State (381)
West Virginia (3)
Wisconsin (38)
377,873 Results for "merck sharp and dohmen arecibo puerto rico".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
IGC Pharma’s Puerto Rico CALMA Trial Site Offers Strategic Opportunity in High-Prevalence Alzheimer’s Market
May 23, 2025
·
4 min read
Press Releases
Cardio Diagnostics Broadens Access to Precision Cardiovascular Care with New Practice Partnerships Across U.S. Mainland and Puerto Rico
May 20, 2025
·
5 min read
Press Releases
Enthea to Present at the 2025 Sequire Investor Summit in Puerto Rico
January 17, 2025
·
2 min read
Press Releases
Autoimmunity BioSolutions to Present at the 2025 Sequire Investor Summit in Puerto Rico
January 16, 2025
·
2 min read
Press Releases
Hemostemix Presents at Puerto Rico Investor Summits: Showcasing Global Scale-Up Strategy and Economic Impact
January 20, 2025
·
7 min read
Policy
Emmaus Life Sciences Receives Marketing Authorization for Puerto Rico
Emmaus Life Sciences, Inc., a leader in sickle cell disease treatment, announced that it has received marketing authorization from the Puerto Rico Department of Health for Endari®.
February 2, 2024
·
4 min read
Press Releases
Hemostemix Up-Lists to OTCQB While it Presents its Global Scale-Up Strategy at Two Investor Conferences in Puerto Rico
January 23, 2025
·
7 min read
M&A
Merck Makes Big Respiratory Play With $10B Acquisition of Verona
In the second biggest acquisition of the year, Merck gains the commercial COPD drug Ohtuvayre, which could help offset the loss of revenue when Keytruda’s patent expires later this decade.
July 9, 2025
·
2 min read
·
Tristan Manalac
Cancer
Arcus Kidney Cancer Drug Casdatifan Advances to Challenge Merck’s Welireg
Updated Phase I/Ib data in hand, Arcus will launch a Phase III trial as it aims to compete with Merck, whose drug secured approval for a type of kidney cancer in 2023.
June 2, 2025
·
2 min read
·
Nick Paul Taylor
RSV
Merck Wins FDA Nod for RSV Antibody, Tees Up Challenge to Sanofi, AstraZeneca
Merck’s Enflonsia will go up against Sanofi and AstraZeneca’s Beyfortus, which the partners plan to ship out early in the third quarter.
June 10, 2025
·
2 min read
·
Tristan Manalac
1 of 37,788
Next
